References
- FriedrichBMDziubaNLiGEndsleyMAMurrayJLFergusonMRHost factors mediating HIV-1 replicationVirus Res2011161210111421871504
- JonckheereHDe ClercqEAnnéJFidelity analysis of HIV-1 reverse transcriptase mutants with an altered amino-acid sequence at residues Leu74, Glu89, Tyr115, Tyr183 and Met184Eur J Biochem200026792658266510785387
- amfAR. [webpage on the Internet]Statistics: Worldwide: The Foundation for AIDS Research: HIV/AIDS Research Available from http://www.amfar.org/worldwide-aids-stats/Accessed March 8, 2016
- MoonsamySDashRCSolimanMEIntegrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysisMolecules20141945243526524762964
- SinghKMarchandBKirbyKAMichailidisESarafianosSGStructural aspects of drug resistance and inhibition of HIV-1 reverse transcriptaseViruses20102260663820376302
- AbadMJBedoyaLMBermejoPTangYi-WeiHIV-screening strategies for the discovery of novel HIV-inhibitorsRecent Translational Research in HIV/AIDS200722457468
- Jacobo-MolinaAArnoldEHIV reverse transcriptase structure-function relationshipsBiochemistry19913026635163561711368
- ChongPSebaharPYoungmanMRational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseJ Med Chem20125523106011060923137340
- UsachIMelisVPerisJENon-nucleoside reverse transcriptase inhibitors : a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityJ Int AIDS Soc20131611424008177
- BarrecaMLRaoADe LucaLDiscovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strainsBioorg Med Chem Lett20071771956196017276064
- DistintoSEspositoFKirchmairJIdentification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approachEur J Med Chem20125021622922361685
- KellerPABirchCLeachSPTyssenDGriffithRNovel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitorJ Mol Graph Model200321536537312543135
- PentaAGangulySMurugesanSDesign and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptaseOrg Med Chem Lett201331823968361
- RenJMiltonJWeaverKLShortSAStuartDIStammersDKStructural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptaseStructure20008101089109411080630
- ZavodszkyMIRohatgiAVan VoorstJRYanHKuhnLAScoring ligand similarity in structure-based virtual screeningJ Mol Recognit200922428029219235177
- SolimanMEA hybrid structure/pharmacophore-based virtual screening approach to design potential leads: A computer-aided design of South African HIV-1 subtype C protease inhibitorsDrug Dev Res2013745283295
- GuWImpact of virtual screening on HIV reverse transcriptase inhibitor discoveryJacobs Journal of AIDS/HIV20141415
- VyasVJainAJainAGuptaAVirtual screening: A fast tool for drug designSci Pharm200876333360
- SkeltonAAMaharajYRSolimanMETarget-bound generated pharmacophore model to improve the pharmacophore-based virtual screening: Identification of G-protein human CCR2 receptors inhibitors as anti-inflammatory drugsCellular and Molecular Bioengineering2014714557
- LavecchiaADi GiovanniCVirtual screening strategies in drug discovery: a critical reviewCurr Med Chem201320232839286023651302
- YoungDCComputational Drug Design: A Guide for Computational and Medicinal ChemistsWiley-Interscience2009
- YangSYPharmacophore modeling and applications in drug discovery: challenges and recent advancesDrug Discov Today20101511–1244445020362693
- MallipeddiPLKumarGWhiteSWWebbTRRecent advances in computer-aided drug design as applied to anti-influenza drug discoveryCurr top Med Chem201414161875188925262796
- WillettPEnhancing the effectiveness of ligand-based virtual screening using data fusionQSAR Comb Sci2006251211431152
- DrwalMNGriffithRCombination of ligand- and structure-based methods in virtual screeningDrug Discov Today Technol2013103e395e40124050136
- KhannaMWangFJoITargeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasionACS Chem Biol20116111232124321875078
- AmaroREBaronRMcCammonJAAn improved relaxed complex scheme for receptor flexibility in computer-aided drug designJ Comput Aided Mol Des200822969370518196463
- OkimotoNFutatsugiNFujiHHigh-performance drug discovery: computational screening by combining docking and molecular dynamics simulationsPLoS Comput Biol2009510e100052819816553
- WangLGuQZhengXDiscovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformationsJ Chem Inf Model20135392409242223901876
- RastelliGEmerging topics in structure-based virtual screeningPharm Res20133051458146323468050
- IslamMAPillayTSExploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identificationJ Mol Graph Model201556203025541527
- ShoichetBKMcGovernSLWeiBIrwinJJLead discovery using molecular dockingCurr Opin Chem Biol20026443944612133718
- HanwellMDCurtisDELonieDCVandermeerschTZurekEHutchisonGRAvogadro: an advanced semantic chemical editor, visualization, and analysis platformJ Cheminform20124111722236646
- PettersenEFGoddardTDHuangCCUCSF Chimera – a visualization system for exploratory research and analysisJ Comput Chem200425131605161215264254
- CaseDABerrymanJTBetzRMAMBER 2015University of CaliforniaSan Francisco Available from ambermd.org/doc12/Amber15.pdf
- GötzAWWilliamsonMJXuDPooleDLe GrandSWalkerRCRoutine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized BornJ Chem Theory Comput2012851542155522582031
- DuanYWuCChowdhurySA point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculationsJ Comput Chem200324161999201214531054
- Antony DhivyanJEAnoopMNVirtual screening and lead optimization to identify novel inhibitors for HDAC-820129158 Available from http://arxiv.org/ftp/arxiv/papers/1209/1209.2793.pdf
- HarveyMJDe FabritiisGAn implementation of the Smooth Particle Mesh Ewald Method on GPU HardwareJ Chem Theory Comput2009592371237726616618
- WuXBrooksBRSelf-guided Langevin dynamics simulation methodChem Phys Lett2003381512518
- KräutlerVVan GunsterenWFHünenbergerPHA fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulationsJ Comput Chem2001225501508
- BerendsenHJCPostmaJPMvan GunsterenWFDiNolaAHaakJRMolecular dynamics with coupling to an external bathJ Chem Phys19848136843690
- TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
- mgltools.scripps.edu [homepage on the Internet]MGLTools Website – Welcome – MGLTools Available from: http://mgltools.scripps.edu/Accessed February 14, 2016
- MorrisGMGoodsellDSHallidayRSAutomated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJ Comput Chem1998191416391662
- HouTWangJLiYWangWAssessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingJ Comput Chem201132586687720949517
- LynePDLambMLSaehJCAccurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoringJ Med Chem200649164805480816884290
- KoesDRCamachoCJZINCPharmer: pharmacophore search of the ZINC databaseNucleic Acids Res201240Web Server issue409414
- IrwinJJShoichetBKZINC – a free database of commercially available compounds for virtual screeningJ Chem Inf Model200545117718215667143
- KawasakiYFreireEFinding a better path to drug selectivityDrug Discov Today20111698599021839183
- Kroeger SmithMBRouzerCATaneyhillLAMolecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activityProtein Sci1995410220322228535257
- RodgersDWGamblinSJHarrisBAThe structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1Proc Natl Acad Sci U S A1995924122212267532306
- DasKMartinezSEBandwarRPArnoldEStructures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavageNucleic Acids Res201442128125813724880687
- MadridMJacobo-MolinaADingJArnoldEMajor subdomain rearrangement in HIV-1 reverse transcriptase simulated by molecular dynamicsProteins199935333233710328268
- TemizNABaharIInhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptaseProteins2002491617012211016